Cancer screening during the COVID-19 pandemic: A systematic review and meta-analysis

CONCLUSION: We found moderate level evidence showing significant decreases in cancer screening for breast, colon, and cervical cancers during the COVID-19 pandemic, which may add further morbidity and mortality to this public health crisis.PMID:34693211 | PMC:PMC8520861 | DOI:10.1016/j.mayocpiqo.2021.10.003

Source: Clinical Breast Cancer - October 25, 2021 Category: Cancer & Oncology Authors: MacKenzie Mayo Bindu Potugari Rami Bzeih Caleb Scheidel Carolyn Carrera Richard A Shellenberger Source Type: research